We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002001:SZSEZhejiang NHU Company Ltd. Analysis

Data as of 2026-06-19 - not real-time

CN¥28.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Undervalued on a fundamental basis – the stock trades at a trailing PE of 12.8x, well below the industry average of 24.1x, and the DCF model suggests a fair value of ≈48 CNY, implying roughly a 37% upside. Revenue is expanding at a healthy 15.7% YoY with robust gross (42.7%) and operating (35%) margins, and ROE sits at a strong 20.4%, all supported by a solid cash position that exceeds debt by nearly 5 billion CNY. The company does not pay a dividend, so income‑focused investors should not count on dividend yield. Technically, the price is hovering just above the 200‑day SMA (28.39) but below the 20‑day (30.11) and 50‑day (32.77) averages, with RSI at 36 indicating slight oversold conditions and a bearish MACD histogram. Volume is trending upward, and the current price of 28 CNY sits near the identified support level of 27.33 CNY, while resistance lies around 32.79 CNY. Market sentiment is in the “Extreme Greed” zone (Fear‑Greed Index 91.5), suggesting bullish bias but also heightened volatility (42% over 30 days) and a recent max drawdown of nearly 30%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price near support at 27.33 CNY
  • Bearish MACD but RSI indicates slight oversold
  • Increasing volume suggests potential bounce

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~37% to 48 CNY
  • Strong earnings growth and margins
  • Technical target near resistance at 32.79 CNY

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term fair value of ~48 CNY indicates >70% upside
  • Sustainable cash generation and low net debt
  • Sector tailwinds in specialty pharma and nutrition

Key Metrics & Analysis

Financial Health

Revenue Growth15.70%
Profit Margin29.05%
P/E Ratio12.8
ROE20.44%
ROA10.65%
Debt/Equity21.31
P/B Ratio2.5
Op. Cash FlowCN¥8.9B
Free Cash FlowCN¥5.7B
Industry P/E24.1

Technical Analysis

TrendNeutral
RSI36.3
SupportCN¥27.33
ResistanceCN¥32.79
MA 20CN¥30.11
MA 50CN¥32.77
MA 200CN¥28.39
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair ValueCN¥47.88
Target PriceCN¥38.34
Upside/Downside36.93%
GradeUndervalued
TypeBlend

Risk Assessment

Beta-0.10
Volatility42.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.